Carpenter Technology Corporation (CRS) Hits Fresh High: Is There Still Room to Run?Zacks Investment Research • 06/10/26
Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE® (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19Business Wire • 06/10/26
Carpenter Technology (CRS) Is Up 8.03% in One Week: What You Should KnowZacks Investment Research • 06/04/26
Carpenter (CRS) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 04/29/26
Carpenter Technology (CRS) Surpasses Q3 Earnings and Revenue EstimatesZacks Investment Research • 04/29/26
CRS Gears Up to Report Q3 Earnings: What's in Store for the Stock?Zacks Investment Research • 04/27/26
Carpenter Technology (CRS) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 04/22/26
ATI vs. CRS: Which Specialty Metals Stock Should You Invest in Now?Zacks Investment Research • 03/25/26
Carpenter Technology (CRS) Just Flashed Golden Cross Signal: Do You Buy?Zacks Investment Research • 03/10/26